Arrowhead Pharmaceuticals · Health Care
ARWR
$74.30
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California.ArrowheadPharmaceuticals,Inc.是一家公开交易的生物制药公司，总部位于加利福尼亚州帕萨迪纳。
Speculative / unprofitable投机／未盈利
Large cap大盘
$10B
Engine stance引擎立场2026-07-20
Constructive — building a base建设性 — 正在筑底
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 71.38.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 71.38 下方。
Key Statistics关键统计
Price价格
$74.30
14.6% below 52-week high低于52周高点 14.6%
Market Cap市值
$10B
Normal volume正常成交量
Beta贝塔
1.51
Moves about 1.5x the market波动幅度约为市场的 1.5 倍
RSI (14)RSI（14）
43
Neutral zone中性区域
Next Earnings下次财报
2026-08-06 (18d)
Volatility Rank波动率分位
19th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
6.1% of float
Performance价格表现
| Period周期 | ARWR | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -2.7% | -1.5% | Lagged the index by 1.2 points落后指数 1.2 个百分点 |
| 1 Month近1月 | -8.3% | +0.6% | Lagged the index by 8.9 points落后指数 8.9 个百分点 |
| 3 Months近3月 | +6.9% | +4.7% | Beat the index by 2.2 points跑赢指数 2.2 个百分点 |
| 6 Months近6月 | +16.4% | +7.8% | Beat the index by 8.6 points跑赢指数 8.6 个百分点 |
| Year to date年初至今 | +9.6% | +9.1% | In line with the index与指数基本持平 |
| 1 Year近1年 | +294.2% | +19.4% | Beat the index by 274.8 points跑赢指数 274.8 个百分点 |
| 3 Years近3年 | +112.3% | +69.4% | Beat the index by 42.9 points跑赢指数 42.9 个百分点 |
Technicals技术面
RSI (14)RSI（14）
43
Neutral zone中性区域
vs 50-day相对50日均线
-4.0% vs 50-day avg
vs 200-day相对200日均线
+18.3% vs 200-day avg
Volatility rank波动率分位
19th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$71.45
Don't chase above不追高于
$74.30
Stop止损
$71.38
Bounce — turn not confirmed; wait反弹 — 转向未确认，先观望
Earnings财务业绩
18
days until next report天后公布财报
2026-08-06
Estimates being raised — 2 analysts预期上调 — 2 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | ARWR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 17.96x | 3.52 | 6% |
| P/S市销率 | 12.31x | 3.02 | 8% |
| Earnings yield盈利收益率 | -0.02% | 2.72 | 25% |
| FCF yield自由现金流收益率 | 1.54% | 3.94 | 22% |
| EV/EBITDA企业价值/EBITDA | 82.80x | 18.21 | 4% |
| P/FCF市值/自由现金流 | 65.07x | 22.42 | 10% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 56.6%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
-0.3%Return on Equity股本回报率
-0.1%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -1.88 |
| Current ratio流动比率 | 4.86 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $63.4M |
| Share count change (1y)股数变化（1年） | +9.4% |
Piotroski皮奥特罗斯基 4/7
Altman Z阿尔特曼Z: safe (6.5)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 10% of its sector on blended multiples综合估值倍数低于行业内 10% 的公司
Beta市场敏感度
1.51×
0.21×3×
Moves about 1.5× the market波动幅度约为市场的 1.5 倍
Financial Health财务健康
4/7
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed -28.2%空头仓位变动 -28.2%
Technical技术面
ARWR weekly MACD crossed downARWR 周线MACD下穿
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$34.9M net (0 buyers, 8 sellers)-$34.9M 净值（0 买家，8 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 0.7% | 2026-03-31 |
| RTW Investments | B | Holding持有 | 0.4% | 2026-03-31 |
Signal History信号历史
COUNTERTREND BOUNCE
UNCONFIRMED TURN
Jul 10, 2026
ARWR weekly MACD crossed downARWR 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Jul 10, 2026
ARWR daily MACD crossed downARWR 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $76.40.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$76.40。
Jul 9, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 6, 2026
BUY ZONE → BOTTOMING买入区 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
NEARING A LOW → BUY ZONE接近低点 → 买入区
BUY买入
Jul 2, 2026
ARWR made a new 52-week highARWR 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $83.99.价格创出52周新高 — 全市场关注的动量/趋势极值。$83.99。
Jul 1, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jun 30, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Showing last 15 of显示最近15条，共 243 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -1.15
Value价值
-1.1
Quality质量
+1.2
Investment资本投入
-3.0
Low volatility低波动
-1.8
Low market beta低市场敏感度
-0.9
Earnings quality盈利质量
+1.5
Short interest空头兴趣
+0.6
Company Profile公司档案
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California.ArrowheadPharmaceuticals,Inc.是一家公开交易的生物制药公司，总部位于加利福尼亚州帕萨迪纳。
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。